JP6823244B2 - ステロイド骨格含有化合物検出デバイスおよびこれを用いたステロイド骨格含有化合物の検出方法 - Google Patents
ステロイド骨格含有化合物検出デバイスおよびこれを用いたステロイド骨格含有化合物の検出方法 Download PDFInfo
- Publication number
- JP6823244B2 JP6823244B2 JP2019508523A JP2019508523A JP6823244B2 JP 6823244 B2 JP6823244 B2 JP 6823244B2 JP 2019508523 A JP2019508523 A JP 2019508523A JP 2019508523 A JP2019508523 A JP 2019508523A JP 6823244 B2 JP6823244 B2 JP 6823244B2
- Authority
- JP
- Japan
- Prior art keywords
- region
- dimensional
- nucleic acid
- sensor
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims description 118
- 150000001875 compounds Chemical class 0.000 title claims description 76
- 238000000034 method Methods 0.000 title claims description 26
- 125000002345 steroid group Chemical group 0.000 title 2
- 230000015572 biosynthetic process Effects 0.000 claims description 263
- 150000007523 nucleic acids Chemical class 0.000 claims description 143
- 102000039446 nucleic acids Human genes 0.000 claims description 124
- 108020004707 nucleic acids Proteins 0.000 claims description 124
- 230000000295 complement effect Effects 0.000 claims description 99
- 150000003431 steroids Chemical group 0.000 claims description 80
- 125000003729 nucleotide group Chemical group 0.000 claims description 79
- 230000000903 blocking effect Effects 0.000 claims description 60
- 108091033319 polynucleotide Proteins 0.000 claims description 60
- 239000002157 polynucleotide Substances 0.000 claims description 60
- 102000040430 polynucleotide Human genes 0.000 claims description 60
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 55
- 230000008878 coupling Effects 0.000 claims description 50
- 238000010168 coupling process Methods 0.000 claims description 50
- 238000005859 coupling reaction Methods 0.000 claims description 50
- 239000002773 nucleotide Substances 0.000 claims description 39
- 229960000890 hydrocortisone Drugs 0.000 claims description 27
- 230000000087 stabilizing effect Effects 0.000 claims description 24
- 230000007423 decrease Effects 0.000 claims description 18
- 239000003792 electrolyte Substances 0.000 claims description 13
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 10
- 230000005764 inhibitory process Effects 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- -1 steroid compound Chemical class 0.000 description 139
- 238000000137 annealing Methods 0.000 description 31
- 108091028043 Nucleic acid sequence Proteins 0.000 description 18
- 230000007246 mechanism Effects 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- 230000006641 stabilisation Effects 0.000 description 9
- 238000011105 stabilization Methods 0.000 description 9
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 230000005669 field effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 5
- 108091023037 Aptamer Proteins 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 108091081406 G-quadruplex Proteins 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000008151 electrolyte solution Substances 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- ZMITXKRGXGRMKS-UHFFFAOYSA-N Androsteronsulfat-pyridiniumsalz Natural products C1C(OS(O)(=O)=O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 ZMITXKRGXGRMKS-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 1
- 229920013685 Estron Polymers 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- ZMITXKRGXGRMKS-HLUDHZFRSA-N androsterone sulfate Chemical compound C1[C@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 ZMITXKRGXGRMKS-HLUDHZFRSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- QGXBDMJGAMFCBF-LUJOEAJASA-N epiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-LUJOEAJASA-N 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960002847 prasterone Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000006177 thiolation reaction Methods 0.000 description 1
- 229950000329 thiouracil Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/403—Cells and electrode assemblies
- G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017061808 | 2017-03-27 | ||
| JP2017061808 | 2017-03-27 | ||
| PCT/JP2017/034996 WO2018179514A1 (fr) | 2017-03-27 | 2017-09-27 | Dispositif de détection de composé contenant un squelette stéroïde et procédé de détection de composé contenant un squelette stéroïde l'utilisant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2018179514A1 JPWO2018179514A1 (ja) | 2019-11-21 |
| JP6823244B2 true JP6823244B2 (ja) | 2021-02-03 |
Family
ID=63677658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508523A Active JP6823244B2 (ja) | 2017-03-27 | 2017-09-27 | ステロイド骨格含有化合物検出デバイスおよびこれを用いたステロイド骨格含有化合物の検出方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP6823244B2 (fr) |
| WO (1) | WO2018179514A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020014061A (es) * | 2018-12-21 | 2021-05-27 | Illumina Inc | Sistemas de deteccion. |
| JP2021032607A (ja) * | 2019-08-20 | 2021-03-01 | 学校法人早稲田大学 | アプタマー固定化半導体センシングデバイス及び非荷電分子の検出方法 |
| JP7276774B2 (ja) * | 2019-11-12 | 2023-05-18 | 学校法人早稲田大学 | アプタマー固定化半導体センシングデバイス及び非荷電分子の検出方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5949767B2 (ja) * | 2011-07-25 | 2016-07-13 | 日本電気株式会社 | 標的物質の検出方法 |
| RU2014125242A (ru) * | 2011-11-23 | 2015-12-27 | Дзе Гавернинг Каунсил Оф Дзе Юниверсити Оф Торонто | Универсальный и чувствительный биодатчик |
| JP6642859B2 (ja) * | 2015-12-11 | 2020-02-12 | Ｎｅｃソリューションイノベータ株式会社 | コルチゾール分析用センサ、コルチゾール分析方法、ストレス評価試薬、ストレス評価方法、コルチゾール関連疾患の試験試薬、およびコルチゾール関連疾患の罹患可能性を試験する方法 |
-
2017
- 2017-09-27 WO PCT/JP2017/034996 patent/WO2018179514A1/fr active Application Filing
- 2017-09-27 JP JP2019508523A patent/JP6823244B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2018179514A1 (ja) | 2019-11-21 |
| WO2018179514A1 (fr) | 2018-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9335292B2 (en) | Electrochemical proximity assay | |
| JP6823244B2 (ja) | ステロイド骨格含有化合物検出デバイスおよびこれを用いたステロイド骨格含有化合物の検出方法 | |
| RU2678996C2 (ru) | Способ обнаружения модификаций днк и связывания с белком путем манипуляций с одиночными молекулами | |
| Asare-Okai et al. | A modified fluorescent intercalator displacement assay for RNA ligand discovery | |
| US20190112593A1 (en) | Method for the selection of aptamers for unbound targets | |
| US11713483B2 (en) | Method for detection of analytes via polymer complexes | |
| Chen et al. | A new colorimetric platform for ultrasensitive detection of protein and cancer cells based on the assembly of nucleic acids and proteins | |
| JP5266828B2 (ja) | メチル化されたｄｎａの含量を測定する方法 | |
| US10233442B2 (en) | Method for affinity purification | |
| US10471057B2 (en) | Toxic RNA inhibitors self-assembled in situ | |
| Ma et al. | A G-triplex based molecular beacon for label-free fluorescence “turn-on” detection of bleomycin | |
| Brosh Jr et al. | Enzymatic mechanism of the WRN helicase/nuclease | |
| US20230042710A1 (en) | Electrochemical proximity assay | |
| EP3365350B1 (fr) | Immuno-essai en sandwich d'adn multiplex (mdisa) | |
| Xiong et al. | Detection of unique Ebola virus oligonucleotides using fluorescently-labeled phosphorodiamidate morpholino oligonucleotide probe pairs | |
| JP6570086B2 (ja) | 検出デバイスおよびこれを用いたターゲットの検出方法 | |
| US20220011304A1 (en) | Biosensor and method for detection of analytes | |
| JP5303981B2 (ja) | Ｄｎａメチル化測定方法 | |
| Wang et al. | Single-molecule recognition of Nucleolin and the interactions with DNA/RNA G-quadruplexes via nanopore decoding | |
| US11279936B2 (en) | Aptamers, biosensors and detection methods for common azole-class antifungal drugs | |
| JP5277681B2 (ja) | Ｄｎａメチル化測定方法 | |
| Foguel et al. | DNA nanotechnology for nucleic acid analysis: sensing of nucleic acids with DNA junction-probes | |
| WO2018119437A2 (fr) | Méthodes et trousses de diagnostic par électrophorèse | |
| WO2018197725A1 (fr) | Biocapteur électrochimique pour la détection d'acides nucléiques | |
| Zhang et al. | Endonuclease Based Hairpin Aptamer Probe for Background Current-eliminated Electrochemical Detection of Thrombin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190724 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190724 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20190724 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190814 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191004 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20191025 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200519 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200717 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201124 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201217 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6823244 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |